menu search

FRLN / New Strong Buy Stocks for July 14

New Strong Buy Stocks for July 14
LE, ING, PD, FRLN and SUNW have been added to the Zacks Rank #1 (Strong Buy) List on July 14, 2023. Read More
Posted: Jul 14 2023, 08:53
Author Name: Zacks Investment Research
Views: 102212

FRLN News  

Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call

By GlobeNewsWire
August 8, 2023

Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call

LONDON, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that it will host a live conference call a more_horizontal

Freeline to Participate in Upcoming Investor Conferences

By GlobeNewsWire
July 31, 2023

Freeline to Participate in Upcoming Investor Conferences

LONDON, July 31, 2023 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that the company will be participating in more_horizontal

New Strong Buy Stocks for July 14

By Zacks Investment Research
July 14, 2023

New Strong Buy Stocks for July 14

LE, ING, PD, FRLN and SUNW have been added to the Zacks Rank #1 (Strong Buy) List on July 14, 2023. more_horizontal

Freeline Therapeutics Holdings PLC Sponsored ADR (FRLN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

By Zacks Investment Research
June 13, 2023

Freeline Therapeutics Holdings PLC Sponsored ADR (FRLN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Freeline Therapeutics Holdings PLC Sponsored ADR (FRLN) witnesses a hammer chart pattern, indicating support found by the stock after losing some valu more_horizontal

Freeline to Present at 22nd Annual Needham Virtual Healthcare Conference

By GlobeNewsWire
April 12, 2023

Freeline to Present at 22nd Annual Needham Virtual Healthcare Conference

LONDON, April 12, 2023 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that its Chief Executive Officer Michae more_horizontal

Freeline to Present at the Stifel Healthcare Conference

By GlobeNewsWire
November 9, 2022

Freeline to Present at the Stifel Healthcare Conference

LONDON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that Chief Executive Officer Michael Parin more_horizontal

Freeline To Present at the 25th Annual Meeting of the American Society of Gene and Cell Therapy

By GlobeNewsWire
May 2, 2022

Freeline To Present at the 25th Annual Meeting of the American Society of Gene and Cell Therapy

Five abstracts accepted with new research and technology insights and data to further enhance AAV-based gene therapy candidates Five abstracts accept more_horizontal


Search within

Pages Search Results: